Navigating the challenges of treatment provision in recurrent/metastatic HNSCC

touchPANEL DISCUSSION for touchONCOLOGY Listen to three experts discuss the treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), including the latest clinical trial data and how it informs clinical practice, and how patient priorities can be established and incorporated into the care plan. The experts Prof. Lisa Licitra - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Dr Aline Chaves - DOM Oncology Group, Divinópolis, Brazil Prof. Joël Guigay - Cancer Center Antoine Lacassagne, Nice, France This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent grant from the healthcare business of Merck KGaA, Darmstadt. This activity is jointly provided by USF Health and touchIME.  For further information visit our website: https://touchoncology.com/cme/treatment-provision-recurrent-metastatic-hnscc/